ArticlePathology oncology research : POR2022

EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits.

Eszter Bencze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.